Public Charity

SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE INC CO WEILL CORNEL

SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE INC CO WEILL CORNEL is a Public Charity headquartered in NEW YORK, NY. Financial data from the 2024 filing: $16.6M revenue, $16.6M expenses, $7.3M total assets.

EIN: 463673346 NEW YORK, NY Medical Research N.E.C. NTEE: H99 Latest filing: 2024

Total Revenue$16.6M

Total Expenses$16.6M

Total Assets$7.3M

Grant Records0

Filing Years2019–2024

Mission

TO FURTHER AND IMPROVE HEALTH AND THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASE THROUGH RESEARCH, GENERATE INNOVATIVE PROOF-OF-CONCEPT STUDIES, AND ADVANCE THE SCIENTIFIC ACTIVITIES OF THE CONTROLLING INSTITUTIONS. (CONTINUED ON SCHEDULE O)THE SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE, INC. WAS ORGANIZED AND IS OPERATED AS AN INDEPENDENT, NON-PROFIT CORPORATION, CONTROLLED BY LEADING NOT-FOR-PROFIT ACADEMIC, MEDICAL AND RESEARCH INSTITUTIONS, TO FURTHER AND IMPROVE HEALTH AND THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASE THROUGH TRANSLATIONAL RESEARCH, GENERATE INNOVATIVE PROOF-OF-CONCEPT STUDIES, AND ADVANCE THE SCIENTIFIC ACTIVITIES OF THE CONTROLLING INSTITUTIONS (MEMORIAL SLOAN KETTERING CANCER CENTER, THE ROCKEFELLER UNIVERSITY, AND WEILL CORNELL MEDICAL COLLEGE) FACULTY, FELLOWS AND STUDENTS IN ASPECTS OF TRANSLATIONAL RESEARCH, CHEMISTRY, PHARMACOLOGY, AND DRUG DISCOVERY.

Where $100 goes at Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel

How Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel divides every $100 it spends, from its own Form 990 filings, averaged across 6 years.

$94 Programs the work itself

$6 Management running the organization

$0 Fundraising none reported

No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.

Inside the $94 for programs

$74

The sanders tri-institutional therapeutics discovery institute, a partnership among three world-renowned scientific and medical institutions, works to more effectively develop therapeutics that arise from discoveries made in basic…

78% of program spending

$20

The institute facilitates more efficient sharing of core facilities between the three partner institutions and forms industry partnerships with pharmaceutical and biotech companies to further advance drug research

22% of program spending

Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

BOARD MEMBER Barbara Hempstead Md

BOARD MEMBER Barry Coller Md

BOARD MEMBER Carl Nathan Md

BOARD MEMBER David Scheinberg Md Phd

BOARD MEMBER Derek Tan Phd

VICE PRESIDENT, BIOLOGICS Manuel Baca

Officer compensation and complete director data available with membership.

Financial Trends

Year	Revenue	Expenses	Assets
2024	$16.6M	$16.6M	$7.3M
2023	$18.7M	$18.7M	$8.0M
2022	$17.0M	$17.0M	$8.8M
2020	$16.6M	$16.8M	$3.9M
2019	$18.0M	$18.4M	$5.9M

Between 2019 and 2024, reported annual revenue declined from $18.0M to $16.6M (-8%), with total assets most recently reported at $7.3M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE INC CO WEILL CORNEL

Complete financials, all 0 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports